Literature DB >> 20452783

Beyond alphabeta/gammadelta lineage commitment: TCR signal strength regulates gammadelta T cell maturation and effector fate.

Sandra M Hayes1, Renee M Laird, Paul E Love.   

Abstract

Signaling by the gammadelta T cell receptor (TCR) is required not only for alphabeta/gammadelta lineage commitment but also to activate and elicit effector functions in mature gammadelta T cells. Notably, at both of these stages, the signal delivered by the gammadeltaTCR is more robust than the one delivered by either the preTCR or the alphabetaTCR. Recent studies now provide evidence that signaling by the gammadeltaTCR is also required at other stages during gammadelta T cell development. Remarkably, the strength of the gammadeltaTCR signal also plays a role at these other stages, as evidenced by the findings that genetic manipulation of gammadeltaTCR signal strength affects gammadelta T cell maturation and effector fate. In this review, we discuss how a strong TCR signal is a recurring theme in gammadelta T cell development and activation. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452783      PMCID: PMC3129014          DOI: 10.1016/j.smim.2010.04.006

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  53 in total

Review 1.  [gamma][delta] cells: a right time and a right place for a conserved third way of protection.

Authors:  A C Hayday
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Long-term survival but impaired homeostatic proliferation of Naïve T cells in the absence of p56lck.

Authors:  B Seddon; G Legname; P Tomlinson; R Zamoyska
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

3.  A population of murine gammadelta T cells that recognize an inducible MHC class Ib molecule.

Authors:  M P Crowley; A M Fahrer; N Baumgarth; J Hampl; I Gutgemann; L Teyton; Y Chien
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

4.  Strain-specific TCR repertoire selection of IL-4-producing Thy-1 dull gamma delta thymocytes.

Authors:  V Azuara; K Grigoriadou; M P Lembezat; C Nagler-Anderson; P Pereira
Journal:  Eur J Immunol       Date:  2001-01       Impact factor: 5.532

5.  Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes.

Authors:  G Legname; B Seddon; M Lovatt; P Tomlinson; N Sarner; M Tolaini; K Williams; T Norton; D Kioussis; R Zamoyska
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

6.  A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.

Authors:  Christi Parham; Madaline Chirica; Jacqueline Timans; Elena Vaisberg; Marilyn Travis; Jeanne Cheung; Stefan Pflanz; Rebecca Zhang; Komal P Singh; Felix Vega; Wayne To; Janet Wagner; Anne-Marie O'Farrell; Terrill McClanahan; Sandra Zurawski; Charles Hannum; Daniel Gorman; Donna M Rennick; Robert A Kastelein; Rene de Waal Malefyt; Kevin W Moore
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

7.  Roles of the Src tyrosine kinases Lck and Fyn in regulating gammadeltaTCR signal strength.

Authors:  Renee M Laird; Sandra M Hayes
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

Review 8.  The SoxD transcription factors--Sox5, Sox6, and Sox13--are key cell fate modulators.

Authors:  Véronique Lefebvre
Journal:  Int J Biochem Cell Biol       Date:  2009-07-30       Impact factor: 5.085

9.  Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signaling and Id3.

Authors:  Eric S Alonzo; Rachel A Gottschalk; Joy Das; Takeshi Egawa; Robin M Hobbs; Pier Paolo Pandolfi; Pablo Pereira; Kim E Nichols; Gary A Koretzky; Martha S Jordan; Derek B Sant'Angelo
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

10.  Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling.

Authors:  J Kang; A Volkmann; D H Raulet
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  7 in total

Review 1.  Selection of self-reactive T cells in the thymus.

Authors:  Gretta L Stritesky; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

2.  Deep sequencing of the human TCRγ and TCRβ repertoires suggests that TCRβ rearranges after αβ and γδ T cell commitment.

Authors:  Anna M Sherwood; Cindy Desmarais; Robert J Livingston; Jessica Andriesen; Maximilian Haussler; Christopher S Carlson; Harlan Robins
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

3.  Differential requirement of RasGRP1 for γδ T cell development and activation.

Authors:  Yong Chen; Xinxin Ci; Balachandra Gorentla; Sarah A Sullivan; James C Stone; Weiguo Zhang; Pablo Pereira; Jianxin Lu; Xiao-Ping Zhong
Journal:  J Immunol       Date:  2012-05-23       Impact factor: 5.422

4.  PreTCR and TCRγδ signal initiation in thymocyte progenitors does not require domains implicated in receptor oligomerization.

Authors:  Juliet Mahtani-Patching; Joana F Neves; Dick John Pang; Kostadin V Stoenchev; Ana M Aguirre-Blanco; Bruno Silva-Santos; Daniel J Pennington
Journal:  Sci Signal       Date:  2011-07-19       Impact factor: 8.192

Review 5.  Signal transduction via the T cell antigen receptor in naïve and effector/memory T cells.

Authors:  Arun Kannan; Weishan Huang; Fei Huang; Avery August
Journal:  Int J Biochem Cell Biol       Date:  2012-09-04       Impact factor: 5.085

6.  Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy.

Authors:  Jie-Jie Geng; Juan Tang; Xiang-Min Yang; Ruo Chen; Yang Zhang; Kui Zhang; Jin-Lin Miao; Zhi-Nan Chen; Ping Zhu
Journal:  EBioMedicine       Date:  2017-05-18       Impact factor: 8.143

Review 7.  Invariant Natural Killer T Cell Subsets-More Than Just Developmental Intermediates.

Authors:  S Harsha Krovi; Laurent Gapin
Journal:  Front Immunol       Date:  2018-06-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.